Clinical Trials Logo

Urinary Incontinence clinical trials

View clinical trials related to Urinary Incontinence.

Filter by:

NCT ID: NCT05390008 Completed - Aging Clinical Trials

The Effects of PFMT and MPE in Elderly Women With SUI.

Start date: July 20, 2020
Phase: N/A
Study type: Interventional

The aim of the study was to compare the effects of PFMT and MPE on SUI frequency and explosure from symptoms, PFM activation response and strength of lumbar stabilizing muscle in elderly women with SUI.

NCT ID: NCT05375344 Recruiting - Clinical trials for Urinary Incontinence, Urge

Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)

MOVEONUP
Start date: June 9, 2022
Phase: N/A
Study type: Interventional

A prospective, two-arm randomized clinical trial utilizing a multidimensional intervention to reduce falls in older women with Urinary Urge Incontinence. The intervention consist of general balance and strength training, bladder training and urge suppression, and home hazard assessments. The control group will receive informational booklets on fall prevention and behavioral treatment for urinary urge incontinence.

NCT ID: NCT05374811 Completed - Multiple Sclerosis Clinical Trials

The Relationship of Neuropathic Pain With Incontinence, Disability and Life Quality in Multiple Sclerosis Patients

Start date: April 15, 2022
Phase:
Study type: Observational

The aim of this study to evaluate the relationship of neuropathic pain with urinary and bowel incontinence, functional disability and quality of life in patients with multiple sclerosis.

NCT ID: NCT05368246 Completed - Clinical trials for Urinary Incontinence

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

Start date: February 15, 2022
Phase: N/A
Study type: Interventional

This clinical investigation is a single-arm, prospective, multicentre, early feasibility study, which is used to evaluate the device design of UCon with respect to initial clinical safety and device performance in a small number of subjects. UCon is a medical device for treatment of the symptoms of overactive bladder (OAB) and bowel disorders (BD). It electrically stimulates the dorsal genital nerve (DGN) through the skin to obtain modulated behaviour of the bladder/bowel musculature e.g., suppress undesired bladder/bowel activity to relieve the symptoms of the patient.

NCT ID: NCT05366426 Recruiting - Clinical trials for Stress Urinary Incontinence

Effect of EMG Biofeedback in Female Patients With Stress Urinary Incontinence

1
Start date: August 19, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized controlled study was to compare the EMG biofeedback method with pelvic floor muscle (PTC) exercises and Sham EMG biofeedback group in women with stress urinary incontinence (SUI) on pelvic floor muscle strength, trunk endurance, subjective perception of improvement, severity of complaints, pad test and quality of life. to determine its effectiveness.

NCT ID: NCT05363644 Withdrawn - Prostate Cancer Clinical Trials

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Start date: April 1, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess functional outcomes post operatively after the use of BioDFence® G3 during robotic radical prostatectomy.

NCT ID: NCT05362292 Recruiting - Clinical trials for Urinary Incontinence

TReating Incontinence for Underlying Mental and Physical Health

TRIUMPH
Start date: October 4, 2022
Phase: Phase 4
Study type: Interventional

The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.

NCT ID: NCT05358769 Completed - Clinical trials for Urinary Incontinence

A Study of Incoxil Food Supplement in Female Patients With Stress Dominant Urinary Incontinence.

Start date: April 27, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is compare the effectiveness of Incoxil food supplement and pelvic floor muscle training with pelvic floor muscle training alone in the treatment of women with stress dominant urinary incontinence.

NCT ID: NCT05356832 Recruiting - Clinical trials for Urinary Incontinence

Investigation of the Relationship Between Pelvic Floor Awareness and Urinary Incontinence

Start date: January 1, 2022
Phase:
Study type: Observational

There is no study in the literature examining the knowledge level and urinary symptoms of active athletes about the pelvic floor. The aim of this study is to determine the relationship between PTC awareness and incontinence in young athletes who engage in long-term and high-intensity activities that increase the risk of SUI.

NCT ID: NCT05355233 Completed - Clinical trials for Urinary Incontinence

Comparative Effects of Bebo Concept and Diaphragmatic Breathing Technique on Stress Incontinence

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Pelvic floor muscle dysfunctions can lead to urinary incontinence, a condition which often affects female both during pregnancy and after childbirth. As a result of this, certain exercises are recommended during and after pregnancy to prevent and treat this incontinence, and the BeBo Concept is one of these methods used to prevent pelvic floor muscle dysfunction. Urinary incontinence among female is considered a social disease, which may affect up to 20-60% of the population of female over 18 years of age. The strength and endurance of the pelvic floor muscles decrease significantly after the first delivery. Research shows that 65% of female with urinary incontinence remember that the first episode of urine loss occurred during pregnancy or in the puerperium. Prior to the study, all participants will be informed of the purpose and method of Conducting the research. . A 6-week physical therapy program according to the BeBo Pelvic Floor Training Concept. Individual meetings will be twice a week, each lasting 60 min. Each meeting will consist of a theoretical part lasting up to 10 min and a practical part lasting about 50 min. In addition, each participant will receive a set of exercises to be performed at home once daily. For the experimental group, In the first week (meetings 1 and 2), the homework will include the following activities: concentration on the pelvic floor muscles and becoming aware of them in various body positions, mobilization of the pelvis in a sitting position on a chair- 10x, lying on the back with bent legs and activation of PFM with exhalation, inhalation- relaxation-10x, balance exercise, standing on one leg, 10 s each leg, and so on to 6 weeks. Treatment protocol for Control Group (Diaphragmatic Breathing), Exercise programs will consist of 1 set of contractions per day and each set will include 30 repetitions for 6 weeks. Female will be asked to complete forms before starting the program and again at the end of the 6-week program.